Furthermore, we measured MMP3 protein level and enzymatic activity in serum from NPC patients and investigated the associations of MMP3 concentration and its activity with patients' clinical outcomes to assess whether serum MMP3 is a valuable diagnostic biomarker for NPC. This evidence concerns the gene MMP3 and nasopharyngeal carcinoma.